NIH-funded research R01 grant

Understanding how chromatin changes in Ewing sarcoma, a type of bone cancer in children and young adults.

Official title: Developmental control of chromatin states in cancer

Funded at Univ of North Carolina Chapel Hill · NIH-10994626 · Data updated 2026-11-12

This study is looking at how a gene fusion called EWS-FLI1 affects the way cancer cells behave in Ewing sarcoma, a type of bone cancer that mostly affects kids and young adults, to find new ways to help treat this disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$424,710
NIH project number5R01CA276663-03
Project IDNIH-10994626 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children and young adults diagnosed with Ewing sarcoma.

Less likely to help

Patients with other types of cancer or those who do not have Ewing sarcoma may not benefit from this research.

What this research studies

This research investigates the role of chromatin states in Ewing sarcoma, a serious bone cancer affecting children and young adults. The study focuses on how a specific gene fusion, EWS-FLI1, influences the behavior of cancer cells by altering chromatin structure. By examining both cancer cells and stem cells, researchers aim to identify the proteins and RNA molecules that contribute to a chromatin environment that supports tumor growth. This approach could lead to new insights into the mechanisms of cancer development and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for Ewing sarcoma, potentially increasing survival rates and reducing the severity of the disease.

How similar studies have gone: Previous research has shown promising results in understanding chromatin dynamics in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Davis, Ian J — Univ of North Carolina Chapel Hill
  • Study coordinator: Davis, Ian J

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.